Purchasing Procedures. 7.1.1 In order to afford CIMAB time to produce sufficient quantities of the Licensed Product as required to treat cancer patients in the Other Countries, TARCANTA, TARCANTA LTD. or their Sublicensees, if any, (hereafter. "Importer" in this Article 7) shall, at least one hundred eighty (180) days prior to the planned first commercial sale within the Other Countries, and quarterly thereafter, TARCANTA LTD. or Sublicensee, if any, (hereafter "Importer" in this Article) will provide CIMAB with a twelve (12) month rolling forecast of its projected orders for Licensed Products in the Other Countries. The Importer will guarantee the purchase of seventy-five percent (75%) of the quantity specified for the first ninety (90) days of each such forecast (the "Firm Commitment Quantities").
Appears in 3 contracts
Sources: License, Development, Manufacturing and Supply Agreement (Cancervax Corp), License, Development, Manufacturing and Supply Agreement (Ym Biosciences Inc), License, Development, Manufacturing and Supply Agreement (Ym Biosciences Inc)